Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors

Clinical trial NCT02014337 · COMPLETED

Trial details

NCT number: NCT02014337
Sponsor: Corcept Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Ovarian Epithelial Cancer Recurrent Sarcoma Non-small Cell Lung Cancer Carcinoma, Transitional Cell Prostate Cancer Prostatic Neoplasms

Start date: 2014-01-01
Primary completion: 2017-12-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.